- Home
- PHVS vs CYD Comparison
PHVS vs CYD Comparison
Compare PHVS & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- CYD
- Stock Information
- Founded
- PHVS 2015
- CYD 1951
- Country
- PHVS Switzerland
- CYD Singapore
- Employees
- PHVS N/A
- CYD N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- CYD Industrial Machinery/Components
- Sector
- PHVS Health Care
- CYD Industrials
- Exchange
- PHVS Nasdaq
- CYD Nasdaq
- Market Cap
- PHVS 1.6B
- CYD 1.5B
- IPO Year
- PHVS 2021
- CYD 1994
- Fundamental
- Price
- PHVS $24.95
- CYD $35.25
- Analyst Decision
- PHVS Buy
- CYD
- Analyst Count
- PHVS 7
- CYD 0
- Target Price
- PHVS $37.00
- CYD N/A
- AVG Volume (30 Days)
- PHVS 282.9K
- CYD 182.2K
- Earning Date
- PHVS 11-12-2025
- CYD 08-08-2025
- Dividend Yield
- PHVS N/A
- CYD 1.50%
- EPS Growth
- PHVS N/A
- CYD 40.10
- EPS
- PHVS N/A
- CYD 1.66
- Revenue
- PHVS N/A
- CYD $3,159,401,156.00
- Revenue This Year
- PHVS N/A
- CYD $41.12
- Revenue Next Year
- PHVS N/A
- CYD $6.93
- P/E Ratio
- PHVS N/A
- CYD $20.99
- Revenue Growth
- PHVS N/A
- CYD 17.99
- 52 Week Low
- PHVS $11.51
- CYD $8.61
- 52 Week High
- PHVS $26.33
- CYD $42.60
- Technical
- Relative Strength Index (RSI)
- PHVS 57.14
- CYD 45.29
- Support Level
- PHVS $23.76
- CYD $33.12
- Resistance Level
- PHVS $26.20
- CYD $36.13
- Average True Range (ATR)
- PHVS 1.77
- CYD 1.88
- MACD
- PHVS 0.19
- CYD -0.33
- Stochastic Oscillator
- PHVS 75.19
- CYD 27.77
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About CYD China Yuchai International Limited
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.